[go: up one dir, main page]

AU2001276005A1 - Method for treating a neoplasm - Google Patents

Method for treating a neoplasm

Info

Publication number
AU2001276005A1
AU2001276005A1 AU2001276005A AU7600501A AU2001276005A1 AU 2001276005 A1 AU2001276005 A1 AU 2001276005A1 AU 2001276005 A AU2001276005 A AU 2001276005A AU 7600501 A AU7600501 A AU 7600501A AU 2001276005 A1 AU2001276005 A1 AU 2001276005A1
Authority
AU
Australia
Prior art keywords
neoplasm
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276005A
Inventor
Stephen Donovan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Sales LLC
Original Assignee
Allergan Sales LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Sales LLC filed Critical Allergan Sales LLC
Publication of AU2001276005A1 publication Critical patent/AU2001276005A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2001276005A 2000-08-02 2001-07-20 Method for treating a neoplasm Abandoned AU2001276005A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63122100A 2000-08-02 2000-08-02
US09631221 2000-08-02
PCT/US2001/022885 WO2002009743A1 (en) 2000-08-02 2001-07-20 Method for treating a neoplasm

Publications (1)

Publication Number Publication Date
AU2001276005A1 true AU2001276005A1 (en) 2002-02-13

Family

ID=24530276

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276005A Abandoned AU2001276005A1 (en) 2000-08-02 2001-07-20 Method for treating a neoplasm

Country Status (4)

Country Link
AR (1) AR030104A1 (en)
AU (1) AU2001276005A1 (en)
TW (1) TWI300717B (en)
WO (1) WO2002009743A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838008B2 (en) 1999-12-07 2010-11-23 Allergan, Inc. Methods for treating diverse cancers
US7838007B2 (en) 1999-12-07 2010-11-23 Allergan, Inc. Methods for treating mammary gland disorders
US8071550B2 (en) * 2003-03-03 2011-12-06 Allergan, Inc. Methods for treating uterine disorders
US8871224B2 (en) 2003-12-09 2014-10-28 Allergan, Inc. Botulinum toxin therapy for skin disorders
US20050220734A1 (en) 2004-04-02 2005-10-06 Allergan, Inc. Therapy for melanin related afflictions
DK2168594T3 (en) 2004-09-23 2015-08-03 Toxcure Inc The treatment of neoplasms with neurotoxin
US8343929B2 (en) 2004-09-23 2013-01-01 Toxcure, Inc. Treating neoplasms with neurotoxin
US10466245B2 (en) 2008-02-20 2019-11-05 The Secretary Of State For Health Covalently linked thermostable kinase for decontamination process validation
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
RU2464937C1 (en) * 2011-05-17 2012-10-27 Федеральное государственное учреждение "Санкт-Петербургский научно-исследовательский институт уха, горла, носа и речи" Министерства здравоохранения и социального развития России (СПб НИИ ЛОР МИНЗДРАВСОЦРАЗВИТИЯ РОССИИ) Method of ablation of paraganglioma of lateral scull base of otiatric shape
RU2615119C1 (en) * 2016-05-23 2017-04-03 государственное бюджетное образовательное учреждение высшего профессионального образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Method of surgical treatment of tympanal glomus
RU2769917C1 (en) * 2021-02-24 2022-04-08 федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Method for surgical management of middle ear masses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466672A (en) * 1992-12-04 1995-11-14 Ophidian Pharmaceuticals, Inc. Therapeutic use of clostridium difficile toxin A
ES2248780T3 (en) * 1993-12-28 2008-06-16 Allergan, Inc. BOTULINIC TOXINS NEUROTOXIC COMPONENT TO TREAT CERVICAL DISTONY.
US6139845A (en) * 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin

Also Published As

Publication number Publication date
TWI300717B (en) 2008-09-11
WO2002009743A1 (en) 2002-02-07
AR030104A1 (en) 2003-08-13

Similar Documents

Publication Publication Date Title
AU2001238369A1 (en) Method for treating thyroid disorders
AU2001245283A1 (en) Methods for treating aneurysms
AU2003299083A1 (en) A method for treating severe tinnitus
AU2002220625A1 (en) Method for producing a strip-shaped object
AU2001277270A1 (en) Method and apparatus for a morphology-preserving smoothing
AU2002210881A1 (en) Transdermal method
AU2001272920A1 (en) A method for treating herpes viruses
AU2001276005A1 (en) Method for treating a neoplasm
AU2001234730A1 (en) Method for inhibiting complement activation
AU2001277938A1 (en) Method for treating angina
AU2001229461A1 (en) Method for inhibiting a tumor
HK1043935A1 (en) Method for treating copd
AU2001280390A1 (en) A method for third party application development
AU2001237530A1 (en) Method
AU2001269422A1 (en) A method for treating celiac disease
AU4696701A (en) Method for carrying out a lottery
AU2001270421A1 (en) Method for providing a demand for skill
AU2001283792A1 (en) Method for automatically identifying a directed structure
AU2001243297A1 (en) Method for treating or preventing depression
AU2001241636A1 (en) Halotherapy method
AU2001266471A1 (en) A method for interactive configuration
AUPQ856700A0 (en) Method for creating geometric figures
EP1335734A4 (en) Method for treating hiv
AU7104798A (en) Synergistic method for treating a neoplasm
AU2002228975A1 (en) Method